Low Circulating Vitamin D in Intensive Care Unit–Admitted COVID-19 Patients as a Predictor of Negative Outcomes
Authors:
- Mikhail V BychininMBMikhail V Bychinin
- Tatiana V KlypaTKTatiana V Klypa
- Irina A MandelIrina A Mandel
- Sergey A AndreichenkoSASergey A Andreichenko
- Vladimir P BaklaushevVBVladimir P Baklaushev
- Gaukhar M YusubalievaGYGaukhar M Yusubalieva
- Nadezhda A KolyshkinaNKNadezhda A Kolyshkina
- Aleksandr V TroitskyATAleksandr V Troitsky
- 1 August 2021
- journal article
- research article
- Published by Elsevier in The Journal of Nutrition
- Vol. 151 (8) , 2199-2205
Abstract
Vitamin D deficiency has been associated with an increased risk of respiratory infections. The study aimed to evaluate the serum 25-hydroxyvitamin D [25(OH)D] concentration in patients admitted to the intensive care unit (ICU) as a predictor of coronavirus disease 2019 (COVID-19) mortality. A single-center retrospective observational study was conducted. Forty adult patients (50% men) with confirmed COVID-19 who were admitted to the ICU were enrolled. The primary endpoint was mortality at day 60. Serum 25(OH)D concentration was measured on the day of admission to the ICU. We used the Mann-Whitney test, Fisher's exact test, Kaplan-Meier analysis, and receiver operator characteristic (ROC) analysis to assess serum 25(OH)D concentration as a predictor of COVID-19 mortality. All 40 patients had a low median (IQR) serum 25(OH)D concentration at admission [12 (9-15) ng/mL]. The median (IQR) serum 25(OH)D concentration was greater in survivors [13.3 (10.0-17.1) ng/mL, n = 22] than in nonsurvivors [9.6 (7.9-14.2) ng/mL; n = 18], P = 0.044. The area under the ROC curve was 0.69 (95% CI: 0.52, 0.86; P = 0.044). The 60-d mortality rate of those with serum 25(OH)D concentrations ≤9.9 ng/mL (n = 14, 71%) tended to be greater than that of those with concentrations >9.9 ng/mL (n = 26, 31%) (P = 0.065), and they had a 5.6-fold higher risk of death (OR: 5.63; 95% CI: 1.35, 23.45; P = 0.018). The ICU patients had a low serum 25(OH)D concentration. Serum 25(OH)D concentrations ≤9.9 ng/mL on admission can be used to predict in-hospital mortality in patients with COVID-19.This trial was registered at clinicaltrials.gov as NCT04450017.Keywords
This publication has 49 references indexed in Scilit:
- Effects of Vitamin D3, Calcipotriol and FTY720 on the Expression of Surface Molecules and Cytolytic Activities of Human Natural Killer Cells and Dendritic CellsToxins, 2013
- Vitamin D status has a linear association with seasonal infections and lung function in British adultsBritish Journal of Nutrition, 2011
- Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill*Critical Care Medicine, 2011
- Plasma 25-Hydroxyvitamin D and Regulation of the Renin-Angiotensin System in HumansHypertension, 2010
- 1α,25-Dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in Human MonocytesCytokine, 2009
- The role of cathelicidin and defensins in pulmonary inflammatory diseasesExpert Opinion on Biological Therapy, 2007
- Low Serum 25-Hydroxyvitamin D Concentrations are Associated with Insulin Resistance and Obesity in Women with Polycystic Ovary SyndromeExperimental and Clinical Endocrinology & Diabetes, 2006
- Epidemic influenza and vitamin DEpidemiology and Infection, 2006
- Noncalcemic Actions of Vitamin D Receptor LigandsEndocrine Reviews, 2005
- VDUP1 Is Required for the Development of Natural Killer CellsImmunity, 2005